NCT06723158 Oral Surgery Virtual Reality Glasses Study
| NCT ID | NCT06723158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston University |
| Condition | Procedural Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-11-18 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-11-18 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomized trial is to investigate if using virtual reality (VR) glasses for patients who require non-emergent oral surgery procedures under intravenous (IV) sedation improves their overall experience compared to using standard of care safety glasses. This study has two primary objectives. 1. To evaluate if VR glasses can improve patient tolerance during IV access, sedation induction, and the surgical procedure. 2. To investigate whether the use of VR glasses reduces the amount of sedation required for induction and throughout the oral surgery procedure. 80 subjects will be randomly assigned 1:1 to either wear VR glasses playing a relaxing video and audio or VR glasses that will only serve as eye protection (control group).
Eligibility Criteria
Inclusion Criteria: * Patients requiring IV sedation for oral surgery procedure * Patients able to understand the use of virtual reality glasses and provide informed consent/assent * Patients classified as American Society of Anesthesiologists (ASA) I or II * No reported substance use within the previous 24 hours * No reported excessive alcohol consumption * Willingness to wear eye protection * Willingness to use certified interpreters if required * A legal guardian must accompany minors Exclusion Criteria: * Patient with hearing aids or severe hearing impairment * Patient with blindness or significant visual impairment that is not corrected by contact lenses * Patients with cognitive impairments determined and assessed by the researchers * Pregnant women or women who could be pregnant based on self reporting * Patients unable to tolerate virtual reality glasses due to motion sickness or other issues * Patients with history of seizures or epilepsy per self report * Patients who cannot tolerate VR glasses due to discomfort or a medical emergency that arises during the procedure
Contact & Investigator
Radhika Chigurupati, DMD MS
PRINCIPAL INVESTIGATOR
Goldman School of Dental Medicine, Oral and Maxillofacial Surgery
Frequently Asked Questions
Who can join the NCT06723158 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 65 Years, studying Procedural Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06723158 currently recruiting?
Yes, NCT06723158 is actively recruiting participants. Contact the research team at rchiguru@bu.edu for enrollment information.
Where is the NCT06723158 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06723158 clinical trial?
NCT06723158 is sponsored by Boston University. The principal investigator is Radhika Chigurupati, DMD MS at Goldman School of Dental Medicine, Oral and Maxillofacial Surgery. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.